Iran and Portugal Pharmaceutical Companies Ready for Cooperation

A joint meeting between Iranian and Portuguese pharmaceutical companies was held in April 29th in Lisbon, Portugal.

Following arrangements made by the Portuguese embassy in Tehran and according to the public relations department of the Iranian Pharmaceutical Industries Syndicate, in this meeting, together with Dr. Mohammad Abdehzadeh, representing the IFDA and Dr. Abbas Kebriaeizadeh, representing the IPIS, a number of major Iranian pharmaceutical companies such as Cinnagen, Dakpha, Kara e-Health Accelerato, Samisaz, Zist Takhmir and IRANPHARMA EXPO secretariat, together with a number of Portuguese companies like Group Azevedos, Medinfar, Tecnifar, EDOL, Basi Lab, Quilaban, Sidefarma, Lab Atral and Genibet were also present.

Furthermore, Dr. Sharifzadeh, chancellor of the faculty of pharmacy at Tehran University of Medical Sciences was present to sign a MoU with Dr. Matilde Fonseca e Castra, chancellor of the faculty of pharmacy at the University of Lisboa, in order to strengthen and expand academic, scientific and cultural ties and put more efforts to find new platforms for exchanging knowledge between universities and holding joint courses.

Pouraqdam, an advisor at the Iranian embassy in Lisbon stated in his interview with the public relations department of the IPIS: “This meeting between Iran and Portugal industries was organized in Lisbon with the arrangements of the Portuguese embassy in Iran and the Iranian embassy in Portugal, together with AICEP and the Iranian Pharmaceutical Industries Syndicate. In terms of pharmaceuticals, Iran and Portugal can complement each there and we hope that by the end of this meeting and following the holding of B2B sessions, both parties will be able to reach tangible and positive results and expand relations.”

It must be noted that the many industries in Portugal announced their bankruptcy back in 2013. As of that year, this country has been trying to turn into an investment destination for major global industries. The Iranian pharmaceutical industry, holding this joint meeting, tends to provide the grounds for Iranian pharmaceuticals to have a platform in the Portuguese market.

Following the joint meeting in April 29th, the Iranian companies paid a visit to the company Sofarimex on April 30th.
According to the public relations department of the IPIS, following the joint meeting between Iranian and Portuguese companies, the general manager at the department of narcotics in the IFDA, the chancellor of the faculty of pharmacy at Tehran University of Medicine, the advisor to the Iranian embassy in Lisbon, together with the companies present at the meeting, paid a visit to Sofarimex factory in Lisbon.

Sofarimex is a pharmaceutical manufacturer in Portugal and produces its products in different forms such as powder, tablets, capsules, syrup, pomade, gel and eye drops.

According to Leila Chegini, expo manager at IRANPHARMA EXPO, these meetings generated great results in expanding the pharmaceutical relations between these two countries. Furthermore, invitations to IRANPHARMA EXPO 2019, the biggest pharmaceutical event of the MENA region, were also delivered to all the participants of this meeting and it was decided that Portuguese companies will have a more expansive participation in the expo and visit the exhibition to continue expanding relations.

The 5th International Exhibition on Pharmaceuticals and Related Industries IRANPHARMA EXPO 2019 will be held in Imam Khomeini Musalla of Tehran in 24-26 September 2019.

News Code 190248

Your Comment

You are replying to: .
3 + 9 =